Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
GPCR
#1522
Structure Therapeutics Inc. American Depositary Shares
53.220
0
USD
-1.90%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-1.90%
Changement Mensuel
-5.39%
Evolution sur 6 mois
+99.03%
Changement Annuel
+99.03%
Clôture Précédente
54.250
0
Open
53.194
0
Bid
Ask
Low
53.194
0
High
53.220
0
Volume
73
Marchés
Actions des Marchés US
Soins de Santé
GPCR
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2023
2024
2025
TTM
Key stats
Total common shares outstanding
46.6 M
57.34 M
70.84 M
—
Valuation ratios
Enterprise value
1.75 B
1.39 B
4.13 B
7.61 B
Price to earnings ratio
-49.86
-34.77
-86.94
-149.54
Price to sales ratio
—
—
—
—
Price to cash flow ratio
-55.99
-36.72
-55.59
-122.51
Price to book ratio
9.83
4.95
8.15
11.44
Enterprise value to EBITDA ratio
—
—
—
—
Profitability ratios
Return on assets %
-0.19
-0.14
-0.09
-0.19
Return on equity %
-0.2
-0.14
-0.09
-0.2
Return on invested capital %
-2 026.88
-2 721.03
-1 075.54
-2 178.26
Gross margin %
—
—
—
—
Operating margin %
—
—
—
—
EBITDA margin %
—
—
—
—
Net margin %
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
Current ratio
19.14
24.74
24.81
82.73
Inventory turnover
—
—
—
—
Asset turnover
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
Debt to equity ratio
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
Per share metrics
Operating cash flow per share
-0.72
-0.74
-1.25
-1.27
EBIT per share
—
—
—
—
EBITDA per share
—
—
—
—
Total debt per share
—
—
—
—
Cash per share
4.24
5.59
8.14
22.12
Net current asset value per share
4.3
5.64
8.84
23.06
Tangible book value per share
4.11
5.48
8.54
22.2
Working capital per share
4.07
5.42
8.49
21.93
Book value per share
4.11
5.48
8.54
22.2
Nouvelles
Structure Therapeutics nomme Matthew Lang directeur des opérations et conseiller juridique
Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?
Structure Therapeutics: The Oral Obesity Inflection, Best-In-Class Efficacy
Qu'est-ce qui se passe avec l'action de Structure Therapeutics mercredi ? | Benzinga France
Structure Therapeutics: A High-Risk, High-Reward Bet On The Next GLP-1 Blockbuster (GPCR)
Wolfe Research initie la couverture de Structure Therapeutics avec une note Peerperform
NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?
Eli Lilly's Experimental Drug Retatrutide Delivers Strong Weight Loss In Late-Stage Trial
Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum?
BMO raises Structure Therapeutics stock price target on obesity drug data
Structure Therapeutics' GLP-1 Agonist Could Be A Potential Acquisition Target (GPCR)
H.C. Wainwright abaisse l’objectif de cours de Structure Therapeutics